Literature DB >> 818020

Comparison of progenitor toxins of nonproteolytic with those of proteolytic Clostridium botulinum Type B.

S Miyazaki, S Kozaki, S Sakaguchi, G Sakaguchi.   

Abstract

A nonproteolytic strain of Clostridium botulinum type B produces two toxins of different molecular weight (16S and 12S) that are indistinguishable from the corresponding toxins of a proteolytic strain in molecular weight and construction but differ in potential toxicity, activation ratio, and hemagglutinability. Successful hybridization between the toxic and nontoxic components (both7S) of 12S toxins of biologically heterologous type B strains confirmed the physico-chemical similarity between the toxic as well as the nontoxic components.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818020      PMCID: PMC420703          DOI: 10.1128/iai.13.3.987-989.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Fish eggs as a cause of human botulism. Two outbreaks in British Columbia due to types E and B botulinus toxins.

Authors:  C E DOLMAN; M TOMSICH; C C CAMPBELL; W B LAING
Journal:  J Infect Dis       Date:  1960 Jan-Feb       Impact factor: 5.226

2.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

3.  Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.

Authors:  G Sakaguchi; S Sakaguchi; S Kozaki; S Sugii; I Oishi
Journal:  Jpn J Med Sci Biol       Date:  1974-06

4.  Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.

Authors:  T Shimizu; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1973-12

5.  Correlation of toxic and non-toxic strains of Clostridium botulinum by DNA composition and homology.

Authors:  W H Lee; H Riemann
Journal:  J Gen Microbiol       Date:  1970-01

6.  Isolation of chromatographically pure toxin of Clostridium botulinum type B.

Authors:  B R DasGupta; D A Boroff; K Cheong
Journal:  Biochem Biophys Res Commun       Date:  1968-09-30       Impact factor: 3.575

7.  Bacteriophages of Clostridium botulinum types A, B, E, and F and nontoxigenic strains resembling type E.

Authors:  M W Eklund; F T Poysky; E S Boatman
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

8.  Significance of 12S toxin of Clostridium botulinum type E.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

9.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Dissociation and reconstitution of 12-S toxin of Clostridium botulinum type E.

Authors:  M Kitamura; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1969-12-23
View more
  5 in total

1.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

2.  Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.

Authors:  S Kozaki; S Miyazaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

Review 3.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

4.  Molecular assembly of botulinum neurotoxin progenitor complexes.

Authors:  Desirée A Benefield; Scott K Dessain; Nancy Shine; Melanie D Ohi; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

5.  Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Authors:  S Kozaki; Y Kamata; T Nishiki; H Kakinuma; H Maruyama; H Takahashi; T Karasawa; K Yamakawa; S Nakamura
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.